AstraZeneca exec stresses Calquence’s patent life ahead of next Medicare negotiationsnews2025-01-22T20:39:55+00:00January 22nd, 2025|Endpoints News|
Vanda loses constitutional fight over FDA’s drug talks with competitorsnews2025-01-22T20:31:17+00:00January 22nd, 2025|Endpoints News|
RFK Jr. says he’ll divest interests in CRISPR Therapeutics if confirmed for HHS chiefnews2025-01-22T16:50:52+00:00January 22nd, 2025|Endpoints News|
J&J’s Spravato wins expanded label for depression as singular treatmentnews2025-01-21T17:58:40+00:00January 21st, 2025|Endpoints News|
Sanofi says no supply interruptions after landing FDA warning letter for US sitenews2025-01-21T17:41:03+00:00January 21st, 2025|Endpoints News|
Exiting Medicare director expects current law to guide next price negotiationsnews2025-01-21T12:00:49+00:00January 21st, 2025|Endpoints News|
FDA approves AstraZeneca and Daiichi Sankyo’s ADC for breast cancer despite lack of survival benefitnews2025-01-17T19:46:40+00:00January 17th, 2025|Endpoints News|
Departing FDA commissioner: ‘We’re losing the battle on misinformation’news2025-01-16T20:59:14+00:00January 16th, 2025|Endpoints News|
FDA rejects Atara’s cell therapy for rare transplant complication, stock cratersnews2025-01-16T14:27:53+00:00January 16th, 2025|Endpoints News|
Eli Lilly’s Omvoh earns FDA approval for Crohn’s diseasenews2025-01-15T22:15:14+00:00January 15th, 2025|Endpoints News|
